ERIS vs RELIANCE
Head-to-head DCF comparison · Eris Lifesciences Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 2 of 4model metrics · not investment advice
ERIS
Eris Lifesciences Limited
General/Diversified
₹1,465
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Overvalued| Metric | ERIS | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Overvalued |
| YieldIQ Score | 46/100 | 46/100 |
| Fair Value | ₹599 | ₹879 |
| Current Price | ₹1,465 | ₹1,353 |
| Margin of Safety | -59.1% | -35.0% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 7/9 | 5/9 |
| ROE | 10.8% | — |
| Debt / Equity | — | 0.36 |
| EV / EBITDA | 20.5× | 12.8× |
| Market Cap | ₹0.20 Lakh Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.